Cargando…

Is the Median Hourly Ambulatory Heart Rate Range Helpful in Stratifying Mortality Risk among Newly Diagnosed Atrial Fibrillation Patients?

Background: The application of heart rate variability is problematic in patients with atrial fibrillation (AF). This study aims to explore the associations between all-cause mortality and the median hourly ambulatory heart rate range ([Formula: see text]) compared with other parameters obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsing-Yu, Malik, John, Wu, Hau-Tieng, Wang, Chun-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622712/
https://www.ncbi.nlm.nih.gov/pubmed/34834554
http://dx.doi.org/10.3390/jpm11111202
Descripción
Sumario:Background: The application of heart rate variability is problematic in patients with atrial fibrillation (AF). This study aims to explore the associations between all-cause mortality and the median hourly ambulatory heart rate range ([Formula: see text]) compared with other parameters obtained from the Holter monitor in patients with newly diagnosed AF. Material and Methods: A total of 30 parameters obtained from 521 persistent AF patients’ Holter monitor were analyzed retrospectively from 1 January 2010 to 31 July 2014. Every patient was followed up to the occurrence of death or the end of 30 June 2017. Results: [Formula: see text] was the most feasible Holter parameter. Lower [Formula: see text] was associated with increased risk of all-cause mortality (adjusted hazard ratio [aHR] for every 10-bpm reduction: 2.70, 95% confidence interval [CI]: 1.75–4.17, p < 0.001). The C-statistic of [Formula: see text] alone was 0.707 (95% CI: 0.658–0.756), and 0.697 (95% CI: 0.650–0.744) for the CHA2DS2-VASc score alone. By combining [Formula: see text] with the CHA2DS2-VASc score, the C-statistic could improve to 0.764 (95% CI: 0.722–0.806). While using 20 bpm as the cut-off value, the aHR was 3.66 (95% CI: 2.05–6.52) for patients with [Formula: see text] < 20 bpm in contrast to patients with [Formula: see text] ≥ 20 bpm. Conclusions: [Formula: see text] could be helpful for risk stratification for AF in addition to the CHA2DS2-VASc score.